OUR CURRENT RESEARCH

Microbiota in COVID-19

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.

Impact of Diet on Gut Microbes

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.

Bile Acids in C. difficile Infection

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.

Pharmacology of Microbiota-Based Therapeutics

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.

Microbiota in Ulcerative Colitis

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.

Sulfate IMT for Ulcerative Colitis

We are developing a clinical trial to use IMT in high risk patients, such as those who are older and have diabetes, high blood pressure, or obesity to prevent COVID-19-associated complications and death.
CLINICAL TRIALS SUPPORTED BY MICROBIOTA THERAPEUTICS PROGRAM

Recurrent C. difficile

The U.S. Department of Veterans Affairs is studying the efficacy of IMT for the prevention of recurrent C. difficile infection (CDI)  after treatment of recurrent CDI with standard antimicrobial therapy.

VA Office of Research and Development

 

Ulcerative Colitis

We are currently recruiting patients with ulcerative colitis for an intestinal microbiota transplant clinical research study.

Parkinson's Disease

We are currently recruiting patients with ulcerative colitis for an intestinal microbiota transplant clinical research study.

Liver Disease

Studying the effects of intestinal microbiota transplant in veterans with cirrhosis.

Hunter Holmes McGuire VA Medical Center, Richmond, VA, PI: Jasmohan Bajaj, MD, MS

 

Pitt Hopkins Syndrome

Intestinal microbiota transplants for children with Pitts Hopkins Syndrome and gastrointestinal disorders.

Arizona State University, PI: James Adams, PhD

 

C. difficile in Solid Organ Transplant Recipients

Studying the effects of intestinal microbiota transplant in solid organ transplant recipients who have a C. difficile infection. University of Wisconsin, Madison, PI: Nasia Safdar, MD, PhD

Autism Spectrum Disorder

Intestinal microbiota transplant for children with autism spectrum disorder who have gastrointestinal disorders.

Arizona State University, PI: James Adams, PhD

 

Leukemia

The University of Minnesota Masonic Cancer Center is recruiting patients for an IMT clinical trial to understand the clinical efficacy of IMT treatment for patients with acute myeloid leukemia and patients receiving allogenic hematopoietic stem cell transplants.

 

Donate to Our Program

Covid-19 and leukemia icons made by Eucalyp from www.flaticon.com

Colon, liver, C. diff, and microscope icons made by smalllikeart from www.flaticon.com

Autism icon made by Smashicons from www.flaticon.com

DNA icon made by phatplus from www.flaticon.com

Vegetable icon made by Freepik from www.flaticon.com

Capsule heart icon made by photo3idea_studio from www.flaticon.com

Poop icons made by photo3idea_studio from www.flaticon.com

Molecule icons made by Freepik from www.flaticon.com</a>

Doctor icon made by srip from www.flaticon.com

Organ icon made by Eucalyp from www.flaticon.com

© 2021 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement